MoneyWorks4Me

Hester Biosciences informs about press release

28 Oct 2021 Evaluate
Hester Biosciences has informed that it enclosed press release titled 'Hester Biosciences Limited Q2 and H1 FY22 Results- Revenue up by 6% and 24%, Net Profit up by 16% and 35%, for Q2 and H1 FY22 - Appointment of additional Directors on the Board'.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1748.90
Dr. Reddys Labs. 1214.10
Cipla 1312.85
Lupin 1954.80
Zydus Lifesciences 1124.00
View more..